Cipla News

Cipla Q3 Results: Net Profit Falls 57% to Rs 676 Crore on Lanreotide Production Halt; India Business Grows 10%

Cipla Q3 Results: Net Profit Falls 57% to Rs 676 Crore on Lanreotide Production Halt; India Business Grows 10%

Cipla Stock Falls After Fresh Concerns here’s what brokerages say

Cipla Stock Falls After Fresh Concerns here’s what brokerages say

Cipla Share Price Today Down 4%; Pharma Stock Among Top Nifty Losers, After USFDA Flags Lapses At Key Partner

Cipla Share Price Today Down 4%; Pharma Stock Among Top Nifty Losers, After USFDA Flags Lapses At Key Partner

IOC, Oil India, Sun Pharma, Cipla, Reliance in Spotlight Due To US-Venezuela Tensions | Target Price Inside

IOC, Oil India, Sun Pharma, Cipla, Reliance in Spotlight Due To US-Venezuela Tensions | Target Price Inside

Cipla Q2 Preview FY2026: Steady Revenue Growth Expected; EBITDA May Decline 4% YoY on Higher R&D Spend

Cipla Q2 Preview FY2026: Steady Revenue Growth Expected; EBITDA May Decline 4% YoY on Higher R&D Spend

Lilly and Cipla Forge Distribution Agreement for Yurpeak, a Type 2 Diabetes and Weight Loss Drug

Lilly and Cipla Forge Distribution Agreement for Yurpeak, a Type 2 Diabetes and Weight Loss Drug

Cipla Q1 Results Preview: Analysts Expect Flat-to-Modest Profit on US Pricing Pressure, Revenue May Rise!

Cipla Q1 Results Preview: Analysts Expect Flat-to-Modest Profit on US Pricing Pressure, Revenue May Rise!

Upcoming Dividend Alert: Pharma Announces 800% Dividend For Shareholders; Should You Buy Before Record Date?

Upcoming Dividend Alert: Pharma Announces 800% Dividend For Shareholders; Should You Buy Before Record Date?

Cipla, Lupin, Zydus Life, Laurus Labs, Mankind Under Pressure: What's Dragging Pharma Stocks Down Today?

Cipla, Lupin, Zydus Life, Laurus Labs, Mankind Under Pressure: What's Dragging Pharma Stocks Down Today?

Cipla Shares Fall 5% As Donald Trump Hints At ‘Never Seen Before’ Tariffs On Pharma Sector; Should You Buy?

Cipla Shares Fall 5% As Donald Trump Hints At ‘Never Seen Before’ Tariffs On Pharma Sector; Should You Buy?

Samina and Rumana Hamied Sell 1.72% Stake in Cipla for Rs 2,111 Crore, Reducing Promoter Holdings

Samina and Rumana Hamied Sell 1.72% Stake in Cipla for Rs 2,111 Crore, Reducing Promoter Holdings

Buy/Sell? Pharma Stock Jumps 10% After Big USFDA Inspection Update, Q2 Profit Up 15.2%

Buy/Sell? Pharma Stock Jumps 10% After Big USFDA Inspection Update, Q2 Profit Up 15.2%

Pharma Major Cipla Declares 15.2% YoY Surge In Q2 Net Profit, Shares In Red; Buy?

Pharma Major Cipla Declares 15.2% YoY Surge In Q2 Net Profit, Shares In Red; Buy?

Stock To Buy: Pharma Giant To Mull Results On Oct 29, TP Rs 1700; Shares Slip 4.80% In 1-Week

Stock To Buy: Pharma Giant To Mull Results On Oct 29, TP Rs 1700; Shares Slip 4.80% In 1-Week

Pharma Stock To Buy: UBS Sees 26.94% Rally, Buy Recommended For TP Rs 2060

Pharma Stock To Buy: UBS Sees 26.94% Rally, Buy Recommended For TP Rs 2060

Rs 13/Sh Dividend: Pharma Stock Declares 7% Rise In Net Profit, Record Date Next Week; Buy?

Rs 13/Sh Dividend: Pharma Stock Declares 7% Rise In Net Profit, Record Date Next Week; Buy?

Rs 13/Share Dividend: Motilal Oswal Lists Large Cap Pharma Stock To Buy, TP Rs 1700

Rs 13/Share Dividend: Motilal Oswal Lists Large Cap Pharma Stock To Buy, TP Rs 1700

Rs 13/Share Dividend Recommended: Buy Pharma Stock For TP Rs 1600, Check Eligibility

Rs 13/Share Dividend Recommended: Buy Pharma Stock For TP Rs 1600, Check Eligibility

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+